Amblyopia Market by Diagnosis, Drug Treatment Therapy, Analysis and Forecasts To 2023

The World Amblyopia Market is expected to grow at a CAGR of ~6.3 % during the forecast period 2017-2023. Amblyopia or lazy eye is a vision development disorder that occurs mainly in children. It is not an eye disease or a type of vision error that can be treated with glasses. It is reduced vision in one eye, caused by abnormal visual development early in life. Amblyopia generally develops from birth up to 7 years of age. It is the leading cause of decreased vision in one eye among children. This disorder commonly affects a single eye but rarely, lazy eye can affect both eyes. The global amblyopia market is driven by increasing number of children with amblyopia.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4353 .

Some of key the players in the market are Amblyoptica (Holding) Pty Ltd (Australia), Pediatric Ophthalmology Associates, Inc. (US), Amblyotech (US), Vivid Vision, Inc. (US), Cigna (US), Appolo VR (US), CooperVision (US), Abbott (US), Novartis AG (Switzerland), ZEISS International (Germany), Johnson & Johnson Services, Inc (US), Kompass (Liibanon).

According to the World Health Organization in 2014, the prevalence of amblyopia across the globe is approximately 1%-5% of total population. It was estimated, that over 19 million children aged less than 15 years were visually impaired; out of which, 12 million are impaired due to incorrected refractive errors and amblyopia. Moreover, increasing prevalence of eye sight affecting diseases, for instance, diabetes, increasing government support and rapid developments in technology have fuelled the growth of the market. On the other hand, high cost of the treatment and unavailability of precise treatment may restrain the growth of the market.

The Americas dominate the global amblyopia market owing to the increasing prevalence of people with amblyopia. Well developed technology and increased patient population with eye sight problems primarily due to increasing prevalence of diabetes. Additionally, high healthcare expenditure, strong government support for research & development and the presence of some of the leading players have fuelled the growth of the market in this region.

Europe is the second largest market across the globe, which is followed by Asia Pacific. Increasing government support and availability of funds for research drive the growth of the market. Asia Pacific is the fastest growing amblyopia market owing to the increasing population, increasing prevalence of ophthalmic diseases,

On the other hand, the Middle East & Africa hold the least share of the market owing to less availability of funds, limited availability of medical facilities, and poor political conditions in Africa.

Get Discount @ https://www.marketresearchfuture.com/check-discount/4353 .

Major TOC for Amblyopia Market:

1 Report Prologue

2 Market Introduction

2.1 Introduction

2.2 Scope of Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

4 Market Dynamics

4.1 Drivers

4.2 Restraints

.... Contineud

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.